Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Liver X receptors α and β regulate renin expression in vivo
Fulvio Morello, Rudolf A. de Boer, Knut R. Steffensen, Massimiliano Gnecchi, Jeffrey W. Chisholm, Frans Boomsma, Leonard M. Anderson, Richard M. Lawn, Jan-Åke Gustafsson, Marco Lopez-Ilasaca, Richard E. Pratt, Victor J. Dzau
Fulvio Morello, Rudolf A. de Boer, Knut R. Steffensen, Massimiliano Gnecchi, Jeffrey W. Chisholm, Frans Boomsma, Leonard M. Anderson, Richard M. Lawn, Jan-Åke Gustafsson, Marco Lopez-Ilasaca, Richard E. Pratt, Victor J. Dzau
View: Text | PDF
Research Article Cardiology

Liver X receptors α and β regulate renin expression in vivo

  • Text
  • PDF
Abstract

The renin-angiotensin-aldosterone system controls blood pressure and salt-volume homeostasis. Renin, which is the first enzymatic step of the cascade, is critically regulated at the transcriptional level. In the present study, we investigated the role of liver X receptor α (LXRα) and LXRβ in the regulation of renin. In vitro, both LXRs could bind to a noncanonical responsive element in the renin promoter and regulated renin transcription. While LXRα functioned as a cAMP-activated factor, LXRβ was inversely affected by cAMP. In vivo, LXRs colocalized in juxtaglomerular cells, in which LXRα was specifically enriched, and interacted with the renin promoter. In mouse models, renin-angiotensin activation was associated with increased binding of LXRα to the responsive element. Moreover, acute administration of LXR agonists was followed by upregulation of renin transcription. In LXRα–/– mice, the elevation of renin triggered by adrenergic stimulation was abolished. Untreated LXRβ–/– mice exhibited reduced kidney renin mRNA levels compared with controls. LXRα–/–LXRβ–/– mice showed a combined phenotype of lower basal renin and blunted adrenergic response. In conclusion, we show herein that LXRα and LXRβ regulate renin expression in vivo by directly interacting with the renin promoter and that the cAMP/LXRα signaling pathway is required for the adrenergic control of the renin-angiotensin system.

Authors

Fulvio Morello, Rudolf A. de Boer, Knut R. Steffensen, Massimiliano Gnecchi, Jeffrey W. Chisholm, Frans Boomsma, Leonard M. Anderson, Richard M. Lawn, Jan-Åke Gustafsson, Marco Lopez-Ilasaca, Richard E. Pratt, Victor J. Dzau

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Nuclear localization of LXRα and LXRβ is not affected by cAMP elevation....
Nuclear localization of LXRα and LXRβ is not affected by cAMP elevation. Double fluorescent immunocytochemistry (magnification, ×400) of As4.1 cells overexpressing N-terminal HA-tagged LXRα (HA-LXRα) or LXRβ (HA-LXRβ) at baseline (top row) and 1 hour after treatment with 1 mM 8-Br-cAMP (bottom row). Control cells expressing GFP alone are also shown. Nuclei were stained with DAPI (blue), and HA-LXRα and HA-LXRβ were detected with an anti-HA monoclonal antibody and with a rhodamine-labeled secondary antibody (red).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts